TARRYTOWN, N.Y., Nov. 16, 2020 /PRNewswire/ -- Regeneron
Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it
has been included on the highly selective Dow Jones Sustainability
World Index (DJSI World) for the second consecutive year. In
addition, Regeneron was named to the Dow Jones Sustainability North
America Index (DJSI North America) for the first time.
DJSI World is a leading global index comprised of organizations
that are corporate leaders in environmental, social and governance
(ESG) practices, representing the top 10 percent of most
sustainable companies in each industry. Regeneron is one of only
four companies in the biotechnology sector to be included on this
year's DJSI World list, and was among 2,500 global companies
eligible for inclusion.
"We are proud to be named again to the prestigious DJSI World
list in recognition of our long-standing commitment to operating
responsibly," said Leonard Schleifer, M.D., Ph.D., President
and Chief Executive Officer of Regeneron. "Regeneron has always
focused on using our unique skills and expertise to improve lives
and create a better world. In 2020, Regeneron has reinforced our
commitment to 'doing well by doing good,' as colleagues across the
company have worked tirelessly to discover and develop a potential
antibody therapy for COVID-19, while at the same time responding to
the needs of our colleagues, patients and communities during this
public health crisis."
Regeneron is dedicated to advancing our responsibility efforts.
Earlier this year, Regeneron announced new global 2025
responsibility goals. These goals span Regeneron's three
responsibility priority areas, focusing on the environmental and
social topics that matter most to our stakeholders and business.
Regeneron will continue to provide an overview of our
sustainability efforts and progress in our annual Responsibility
Report.
"This recognition is a testament to the incredible people of
Regeneron who care deeply about making a positive impact in the
world," said Hala Mirza, Senior Vice President of Corporate
Communications and Citizenship at Regeneron. "This year our
colleagues have particularly come together to further advance
Regeneron's efforts in environmental sustainability, community
support and diversity, equity and inclusion. We will continue to
share our progress transparently as we work to make a positive
impact on society."
About Regeneron
Regeneron (NASDAQ:
REGN) is a leading biotechnology company that invents
life-transforming medicines for people with serious diseases.
Founded and led for over 30 years by physician-scientists, our
unique ability to repeatedly and consistently translate science
into medicine has led to eight FDA-approved treatments and numerous
product candidates in development, all of which were homegrown in
our laboratories. Our medicines and pipeline are designed to help
patients with eye diseases, allergic and inflammatory diseases,
cancer, cardiovascular and metabolic diseases, pain, infectious
diseases and rare diseases.
Regeneron believes that operating as a good corporate citizen is
crucial to delivering on our mission. We approach corporate
responsibility with three goals in mind: to improve the lives of
people with serious diseases, to foster a culture of
integrity and excellence and to build
sustainable communities. Regeneron is proud to be included on the
Dow Jones Sustainability World Index and the Civic 50 list of the
most "community-minded" companies in the
United States. Throughout the year, Regeneron empowers and
supports employees to give back through our volunteering, pro bono
and matching gift programs. Our most significant philanthropic
commitments are in the area of science education, including
the Regeneron Science Talent Search and the Regeneron
International Science and Engineering Fair (ISEF).
For additional information about the company, please
visit www.regeneron.com or follow @Regeneron on
Twitter.
Regeneron Media Relations
Ella Campbell
Tel: +1 (914) 847-7017
ella.campbell@regeneron.com
View original
content:http://www.prnewswire.com/news-releases/regeneron-included-on-dow-jones-sustainability-world-index-for-second-consecutive-year-301173305.html
SOURCE Regeneron Pharmaceuticals, Inc.